Large-scale testing (Phase 3)Study completedNCT02813265
What this trial is testing
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Who this might be right for
Dry Eye SyndromesKeratoconjunctivitis Sicca
Kala Pharmaceuticals, Inc. 918